The European Haemophilia Network (EUHANET).
作者信息
Makris Michael, Calizzani Gabriele, Fischer Kathelijn, Gatt Alexander, Gilman Estelle, Hollingsworth Robert, Lambert Thierry, Lassila Riitta, Mannucci Pier Mannuccio, Peyvandi Flora, Windyga Jerzy
机构信息
Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom Sheffield Haemophilia and Thrombosis Centre, Sheffield, United Kingdom.
National Blood Centre, National Institute of Health, Rome, Italy.
出版信息
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s515-8. doi: 10.2450/2014.0008-14s.
Abstract
摘要
相似文献
1
The European Haemophilia Network (EUHANET).欧洲血友病网络（EUHANET）。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s515-8. doi: 10.2450/2014.0008-14s.
2
The methodology for defining the European standards for the certification of Haemophilia Centres in Europe.欧洲血友病中心认证的欧洲标准定义方法。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s519-24. doi: 10.2450/2014.0046-14s.
3
The European standards of Haemophilia Centres.欧洲血友病中心标准。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s525-30. doi: 10.2450/2014.0056-14s.
4
Haemophilia care in Europe: Past progress and future promise.欧洲血友病护理：过去的进展与未来的前景。
Haemophilia. 2020 Sep;26(5):752-758. doi: 10.1111/hae.14097. Epub 2020 Aug 4.
5
Haemophilia care in Europe: a survey of 19 countries.欧洲血友病护理：19 个国家的调查。
Haemophilia. 2011 Jan;17(1):35-40. doi: 10.1111/j.1365-2516.2010.02362.x. Epub 2010 Aug 16.
6
European principles of inhibitor management in patients with haemophilia.欧洲血友病患者抑制剂管理原则。
Orphanet J Rare Dis. 2018 Apr 27;13(1):66. doi: 10.1186/s13023-018-0800-z.
7
Current co-ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management).
Haemophilia. 2006 Mar;12(2):124-7. doi: 10.1111/j.1365-2516.2006.01202.x.
8
Third and fourth Workshops of the European Paediatric Network for Haemophilia Management.
Haemophilia. 2003 Mar;9(2):223-8. doi: 10.1046/j.1365-2516.2003.00746.x.
9
Addressing current challenges in haemophilia care: consensus recommendations of a European Interdisciplinary Working Group.应对血友病护理中的当前挑战：欧洲跨学科工作组的共识性建议
Haemophilia. 2005 Sep;11(5):433-7. doi: 10.1111/j.1365-2516.2005.01130.x.
10
Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates.克吕特四世：欧洲关于使用凝血因子浓缩物治疗血友病的共识建议。
Haemophilia. 2017 May;23(3):370-375. doi: 10.1111/hae.13211. Epub 2017 Apr 12.
引用本文的文献
1
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.先天性纤维蛋白原异常症：前瞻性罕见出血性疾病数据库的回顾性临床与遗传学分析。
Blood Adv. 2024 Mar 26;8(6):1392-1404. doi: 10.1182/bloodadvances.2023012186.
2
Evolution of Haemophilia Care in Europe: 10 years of the principles of care.欧洲血友病护理的发展：10 年的护理原则。
Orphanet J Rare Dis. 2020 Jul 13;15(1):184. doi: 10.1186/s13023-020-01456-y.
3
Uncovered needs in the management of inherited bleeding disorders in Italy.意大利遗传性出血性疾病管理中未被满足的需求。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s563-6. doi: 10.2450/2014.0036-14s.
4
The European standards of Haemophilia Centres.欧洲血友病中心标准。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s525-30. doi: 10.2450/2014.0056-14s.
5
The methodology for defining the European standards for the certification of Haemophilia Centres in Europe.欧洲血友病中心认证的欧洲标准定义方法。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s519-24. doi: 10.2450/2014.0046-14s.
6
The Italian institutional accreditation model for Haemophilia Centres.意大利血友病中心的机构认证模式。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s510-4. doi: 10.2450/2014.0058-14s.
7
Haemophilia Centre Certification Systems: optional or optimal choice for healthcare systems?血友病中心认证系统：医疗系统的可选还是最佳选择？
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s492-4. doi: 10.2450/2014.0076-14s.
本文引用的文献
1
Haemophilia care in Europe - a survey of 35 countries.欧洲血友病护理 - 35 个国家的调查。
Haemophilia. 2013 Jul;19(4):e239-47. doi: 10.1111/hae.12125. Epub 2013 Apr 4.
2
Guidelines for the management of hemophilia.血友病管理指南。
Haemophilia. 2013 Jan;19(1):e1-47. doi: 10.1111/j.1365-2516.2012.02909.x. Epub 2012 Jul 6.
3
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.罕见出血性疾病的凝血因子活性和临床出血严重程度：来自欧洲罕见出血性疾病网络的结果。
J Thromb Haemost. 2012 Apr;10(4):615-21. doi: 10.1111/j.1538-7836.2012.04653.x.
4
Validity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project.利用登记数据评估血友病患儿抑制剂发展情况的有效性：EUHASS 项目。
Haemophilia. 2012 May;18(3):e241-6. doi: 10.1111/j.1365-2516.2011.02687.x. Epub 2011 Nov 2.
5
A study of variations in the reported haemophilia B prevalence around the world.一项关于全球报道的乙型血友病患病率变化的研究。
Haemophilia. 2012 May;18(3):e91-4. doi: 10.1111/j.1365-2516.2011.02588.x. Epub 2011 Jun 7.
6
EUHASS: The European Haemophilia Safety Surveillance system.欧盟血友病安全监测系统。
Thromb Res. 2011 Jan;127 Suppl 2:S22-5. doi: 10.1016/S0049-3848(10)70150-X.
7
Biovigilance and pharmacovigilance for haemophilia.血友病的生物监测与药物警戒
Haemophilia. 2010 Jul;16 Suppl 5:17-21. doi: 10.1111/j.1365-2516.2010.02288.x.
8
A study of variations in the reported haemophilia A prevalence around the world.一项关于全球范围内报道的血友病 A 患病率变化的研究。
Haemophilia. 2010 Jan;16(1):20-32. doi: 10.1111/j.1365-2516.2009.02127.x. Epub 2009 Oct 21.
9
The natural history of chronic hepatitis C in haemophiliacs.血友病患者慢性丙型肝炎的自然病史。
Br J Haematol. 1996 Sep;94(4):746-52. doi: 10.1046/j.1365-2141.1996.02343.x.
Zotero 插件